𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of phytomedicines, AM-1, niprisan® and nifadin on the pharmacokinetics of chloroquine in rats

✍ Scribed by K. B. Mustapha; M. T. Bakare-Odunola; M. Garba; O. O. Obodozie; I. S. Enemali; U. S. Inyan


Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
555 KB
Volume
34
Category
Article
ISSN
0378-7966

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


No effect of chloroquine on theophylline
✍ Bedassa A. Motti; Michael Ashton 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

The immediate and delayed effects of chloroquine on theophylline kinetics were investigated in rats pretreated with chloroquine diphosphate (45 mg kg -1 ) or saline intraperitoneally. One hour or 4 days after chloroquine, theophylline (10 mg kg -1 ) was administered intravenously. Compared with the

The effect of chloroquine on the pharmac
✍ C. M. Masimirembwa; Y. S. Naik; J. A. Hasler 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 539 KB

It is likely that a proportion of people treated with the anti-schistosomicidal drug praziquantel (PZQ) is also taking other drugs such as chloroquine (CHQ), a widely used anti-malarial. The effect of CHQ on the pharmacokinetics and metabolism of PZQ in rats and in humans was therefore studied. CHQ

The effect of rifampicin and pyrazinamid
✍ Helen M. Baldan; Helene J. De Rosa; Iguatemy L. Brunetti; Valdecir F. Ximenes; R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Tuberculosis chemotherapy involves combination of the drugs isoniazid (INH), rifampicin (RMP) and pyrazinamide (PYR) for a 6-month period. The present work investigated the influence of RMP and PYR on the pharmacokinetic parameters of INH when groups of rats were pre-treated for 21 days with INH alo

The effect of tamoxifen on the pharmacok
✍ X. Tao; A. M. H. Brodie; I. P. Nnane 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 2 views

The effects of single doses of tamoxifen (TAM; 0.5-5 mg/kg, i.v.) and chronic pretreatment with TAM (0.1-5.0 mg/kg/day, i.p. for 7 consecutive days) on letrozole (0.5 mg/kg, i.v.) pharmacokinetics were evaluated in female Sprague-Dawley rats. The plasma concentration-time profiles of letrozole (0.1-